Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jay Lichter files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew Hollman Meyer - $210K in JANX purchases and sales in the last 12 months
- Janeen Noel Doyle - $57K in JANX purchases and sales in the last 12 months
- Maria Dobek - $29K in JANX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jay Lichter?
Jay Lichter is a corporate insider of Janux Therapeutics, Inc. (JANX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jay Lichter last file a Form 4?
The only primary Form 4 on record is dated 24 October 2024.
Has Jay Lichter been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($178K) across all tracked filings.
